SilkTech Biopharmaceuticals develops silk-based anti-inflammatory therapies. Their lead indication is Dry Eye Disease, an inflammatory-based chronic condition.

Biotechnology

SilkTech Biopharmaceuticals

SilkTech Biopharmaceuticals' headquarters in Plymouth, MN, United States

Brian Lawrence

David Infanger

Mark Payne

Emmett Cunningham

Paul M. Karpecki

Edward Holland

Tim Comstock

Debra Schaumberg

Eric Donnenfeld

Brian Levy

Alex Soltani

Bill Mower

Richard L. Lindstrom

Gary D. Novack

The Advisory Team at SilkTech Biopharmaceuticals provides strategic guidance and expert insights to support the development and commercialization of silk-based anti-inflammatory therapies, with a primary focus on Dry Eye Disease. Comprised of seasoned professionals, they offer critical advice on clinical trials, regulatory compliance, market positioning, and potential partnerships.

Advisory Team

The Leadership Team at SilkTech Biopharmaceuticals is responsible for setting the strategic direction and overseeing the overall operations of the company. Comprised of key executives including the CEO, VPs of Research & Development, and the CFO, this team fosters innovation in silk-based therapies, drives financial planning and resource allocation, and ensures alignment with regulatory standards to advance treatment solutions for Dry Eye Disease and other inflammatory conditions.

Leadership Team

SilkTech Biopharmaceuticals

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

SilkTech Biopharmaceuticals

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies